C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2002
11/06/2002	EP1254140A1 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1196398A4 Bridged fluorescent dyes, their preparation and their use in assays
11/06/2002	EP0993459B1 Compounds useful for inhibition of farnesyl protein transferase
11/06/2002	EP0758335B1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/06/2002	CN1378539A Thiocarbamic acid derivatives
11/06/2002	CN1378535A 四氢喹啉衍生物 Tetrahydroquinoline derivative
11/06/2002	CN1378533A Phenoxypropylamine compounds
11/06/2002	CN1093862C Indole derivatives and its preparing method and use
11/06/2002	CN1093860C Pyridazino-[4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
11/06/2002	CN1093767C Protein kinase C inhibitors
11/05/2002	US6476251 Process for preparing spirocyclic tetronic acid derivatives
11/05/2002	US6476226 Isoxazoline fibrinogen receptor antagonists
11/05/2002	US6476225 Combining an aqueous base and 20(s)-camptothecin to convert the lactone ring into a carboxylate salt, hydrogenation in the presnce of a transition metal catalyst, acidifying to form crystals, adding a polar aprotic solvent, and separating
11/05/2002	US6476221 Tribenzazepine compound and production method thereof
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476018 Fused imidazole derivatives as multidrug resistance modulators
11/05/2002	CA2118488C 5-o-desosaminylerythronolide a derivative
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086879A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound
10/31/2002	WO2002086878A2 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers
10/31/2002	WO2002085912A1 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-6,9-DIOXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENE
10/31/2002	WO2002085911A1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 1,4-DIOXINO[2,3-b]PYRIDINE
10/31/2002	WO2002085910A1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085848A2 Synthesis of pancratistatin prodrugs
10/31/2002	WO2002085370A1 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
10/31/2002	WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002	WO2002064574A3 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002	WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002	US20020161231 Intermediate for preparing camptothecin derivatives
10/31/2002	US20020161228 Piperidine compounds
10/31/2002	US20020161034 Spiro-pyran compounds; use as pesticides and herbicides
10/31/2002	US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002	US20020161005 Nitrogen heterocycle compounds
10/31/2002	US20020160996 Benzofuran substituted by a fused nitrogen-containing heterocyclic ring such as isoindoline; inhibits cytotoxicity of beta-amyloid; Alzheimer's or Parkinson's disease
10/31/2002	US20020160994 The beta-hydroxy lactone, such as -(+)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H -oxepino(3',4':6,7)indolizino(1,2-b)quinoline-3,15-dione
10/31/2002	US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002	CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	CA2444471A1 Synthesis of pancratistatin prodrugs
10/29/2002	US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists
10/24/2002	WO2002084656A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g
10/24/2002	WO2002083694A1 Synthesis of silyl camptothecins and silyl homocamptothecins
10/24/2002	WO2002083651A2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002	WO2002083645A1 Novel compounds
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002064597A3 Method for purifying 20(s)-camptothecin
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2001053299A9 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
10/24/2002	US20020156110 Anticancer, antiproliferative and antiarthritic agents
10/24/2002	US20020156095 Treatment of depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, etc.
10/24/2002	US20020155381 Multilayer; radiation transparent substrate, reflection layers, protective coatings
10/24/2002	CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444148A1 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/23/2002	EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002	EP1250926A2 Use of a water-insoluble S-camptothecin with a closed lactone ring in the manufacture of a medicament for treatment of colon cancer
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
10/23/2002	EP0785191B1 Fused indan derivatives and salts thereof
10/23/2002	CN1375490A Novel indeno indolone compound, its preparation method and drug composition comprising the same
10/23/2002	CN1093130C Substituted pyrido 6,6-bicyclic derivatives
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469182 Intermediates in the preparation of macrocyclic analogs
10/22/2002	US6469171 Syntheses of a variety of lamellarin compounds and analogues
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469021 Non-peptide antagonists of GLP-1 receptor and methods of use
10/22/2002	US6469020 Hydroxamic and carboxylic acid derivatives
10/17/2002	WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002080919A1 Therapeutic compounds and methods
10/17/2002	WO2002080846A2 Epothilone derivatives and methods for making and using the same
10/17/2002	WO2002050081A3 Antimicrobial agents
10/17/2002	US20020151713 Substituted 6,5-hetero-bicyclic derivatives
10/17/2002	US20020151553 Such as 4-(4-chlorophenyl)1-(3-(5-cyano-5H-dibenzo(a,d) cycloheptene-5-yl)propyl)piperidin-4-ol for treatment of diseases associated with aberrant leukocyte recruitment and/or activation
10/17/2002	US20020151544 Phosphatidylinositol 3-kinase (PI3K) inhibitors/anticancer agents such as N-(2-(3-benzenesulfonylaminophenyl)-4-morphoniloquinazolin-6-yl)acetamide
10/17/2002	US20020151456 Coupling of an aminopyrazine with a spirolactone
10/17/2002	CA2444024A1 Thiohydantoins and use thereof for treating diabetes
10/16/2002	EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002	EP0944385B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith
10/16/2002	CN1374963A Remedies or preventives for freqent urination or arinary incontinence
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374865A Nociceptin receptor ORL-1 agonists for use in treating cough
10/15/2002	US6465507 Antitumor agents
10/15/2002	US6465479 Pyridomorphinans and use thereof
10/15/2002	US6465472 Substituted quinazolines and analogs and use thereof
10/15/2002	US6465467 Diseases related to the 5-ht2c receptor, especially eating, memory, mood, urinary and anxiety disorders, schizophrenia, pain, sexual dysfunctions
10/15/2002	CA2310926C A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
10/10/2002	WO2002080164A1 Optical recording medium
10/10/2002	WO2002080163A1 Optical data carrier containing a cyclizable compound in the information layer
10/10/2002	WO2002080162A1 Optical data memories containing an axially substituted co-phthalocyanine in the information layer that can be written with light

1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 298